Goodwin Procter LLP advised Chiasma, Inc. on the deal. Chiasma, Inc. (Nasdaq: CHMA) announced its definitive agreement to be acquired by Amryt Pharma plc (Nasdaq: AMYT, AIM:...
Amryt Pharma’s Acquisition of Chiasma
Brighton Park Capital’s $125 Million Growth Investment in OPSWAT
Goodwin Procter LLP advised OPSWAT, Paul, Weiss advised Brighton Park Capital on the deal. OPSWAT announced its $125 million growth investment from Brighton Park Capital. OPSWAT plans...